Senior associate editor at The Atlantic, Rachel Gutman, breaks down her reporting on ‘rebound Covid’ and the rollout of Pfizer’s Paxlovid antiviral treatment.
Senior associate editor at The Atlantic, Rachel Gutman, breaks down her reporting on ‘rebound Covid’ and the rollout of Pfizer’s Paxlovid antiviral treatment.